SB

Smriti Biswas

Director Director DIN 08969260
DIN 08969260 First appointment Nov 2020 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2020
Shareholding value Locked Premium profile

About Smriti Biswas

Smriti Biswas has 5 years in corporate governance. Formerly with 1 company, such as Styla Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08969260
Primary Designation Director
First Appointment 24 Nov 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Styla Pharmaceutical Private Limited U24230CH2020PTC043353
Director 24 Nov 2020 2020 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Styla Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Smriti Biswas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smriti Biswas

Smriti Biswas has 5 years in corporate governance. Formerly with 1 company, such as Styla Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations.

Smriti Biswas is associated with 0 companies as a director.

Smriti Biswas has expertise in General Business.

Smriti Biswas has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available